Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 4 de 4
1.
Int J Mol Sci ; 23(17)2022 Sep 02.
Article En | MEDLINE | ID: mdl-36077450

Methotrexate (MTX) administration is the gold standard treatment for rheumatoid arthritis (RA), but its effects are limited to preventing the progression of the disease. Therefore, effective regenerative therapies for damaged tissues are still to be developed. In this regard, MTX complexes of general molecular formula M(MTX)·xH2O, where M = Sr, Zn, or Mg, were synthesized and physicochemically characterized by TGA, XRD, NMR, ATR-FTIR, and EDAX spectroscopies. Characterization results demonstrated the coordination between the different cations and MTX via two monodentate bonds with the carboxylate groups of MTX. Cation complexation provided MTX with new bioactive properties such as increasing the deposition of glycosaminoglycans (GAGs) and alternative anti-inflammatory capacities, without compromising the immunosuppressant properties of MTX on macrophages. Lastly, these new complexes were loaded into spray-dried chitosan microparticles as a proof of concept that they can be encapsulated and further delivered in situ in RA-affected joints, envisioning them as a suitable alternative to oral MTX therapy.


Antirheumatic Agents , Arthritis, Rheumatoid , Anti-Inflammatory Agents/therapeutic use , Antirheumatic Agents/pharmacology , Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/drug therapy , Humans , Macrophages , Methotrexate/pharmacology , Methotrexate/therapeutic use
2.
Eur J Med Chem ; 212: 113152, 2021 Feb 15.
Article En | MEDLINE | ID: mdl-33453601

The development of new drugs for musculoskeletal regeneration purposes has attracted much attention in the last decades. In this work, we present three novel vitamin B9 (folic acid)-derivatives bearing divalent cations (ZnFO, MgFO and MnFO), providing their synthesis mechanism and physicochemical characterization. In addition, a strong emphasis has been placed on evaluating their biological properties (along with our previously reported SrFO) using human mesenchymal stem cells (hMSC). In all the cases, pure folate derivatives (MFOs) with a bidentate coordination mode between the metal and the folate anion, and a 1:1 stoichiometry, were obtained in high yields. A non-cytotoxic dose of all the MFOs (50 µg/mL) was demonstrated to modulate by their own the mRNA profiles towards osteogenic-like or fibrocartilaginous-like phenotypes in basal conditions. Moreover, ZnFO increased the alkaline phosphatase activity in basal conditions, while both ZnFO and MnFO increased the matrix mineralization degree in osteoinductive conditions. Thus, we have demonstrated the bioactivity of these novel compounds and the suitability to further studied them in vivo for musculoskeletal regeneration applications.


Biocompatible Materials/chemistry , Folic Acid/chemistry , Mesenchymal Stem Cells/cytology , Musculoskeletal System/cytology , Tissue Engineering , Biocompatible Materials/chemical synthesis , Cations/chemical synthesis , Cations/chemistry , Cells, Cultured , Drug Carriers/chemical synthesis , Drug Carriers/chemistry , Folic Acid/chemical synthesis , Humans
3.
Int J Mol Sci ; 20(20)2019 Oct 09.
Article En | MEDLINE | ID: mdl-31601031

: Bacterial, protozoan and other microbial infections share an accelerated metabolic rate. In order to ensure a proper functioning of cell replication and proteins and nucleic acids synthesis processes, folate metabolism rate is also increased in these cases. For this reason, folic acid antagonists have been used since their discovery to treat different kinds of microbial infections, taking advantage of this metabolic difference when compared with human cells. However, resistances to these compounds have emerged since then and only combined therapies are currently used in clinic. In addition, some of these compounds have been found to have an immunomodulatory behavior that allows clinicians using them as anti-inflammatory or immunosuppressive drugs. Therefore, the aim of this review is to provide an updated state-of-the-art on the use of antifolates as antibacterial and immunomodulating agents in the clinical setting, as well as to present their action mechanisms and currently investigated biomedical applications.


Anti-Infective Agents/pharmacology , Folic Acid Antagonists/pharmacology , Immunologic Factors/pharmacology , Animals , Anti-Infective Agents/chemistry , Drug Resistance , Folic Acid Antagonists/chemistry , Humans , Immunologic Factors/chemistry , Immunomodulation/drug effects , Microbial Sensitivity Tests , Structure-Activity Relationship
4.
Int J Mol Sci ; 19(12)2018 Dec 16.
Article En | MEDLINE | ID: mdl-30558349

B-vitamins are a group of soluble vitamins which are cofactors of some of the enzymes involved in the metabolic pathways of carbohydrates, fats and proteins. These compounds participate in a number of functions as cardiovascular, brain or nervous systems. Folic acid is described as an accessible and multifunctional niche component that can be used safely, even combined with other compounds, which gives it high versatility. Also, due to its non-toxicity and great stability, folic acid has attracted much attention from researchers in the biomedical and bioengineering area, with an increasing number of works directed at using folic acid and its derivatives in tissue engineering therapies as well as regenerative medicine. Thus, this review provides an updated discussion about the most relevant advances achieved during the last five years, where folic acid and other vitamins B have been used as key bioactive compounds for enhancing the effectiveness of biomaterials' performance and biological functions for the regeneration of tissues and organs.


Folic Acid/pharmacology , Regenerative Medicine , Tissue Engineering , Vitamin B Complex/pharmacology , Animals , Folic Acid/analogs & derivatives , Folic Acid/therapeutic use , Humans , Regenerative Medicine/methods , Tissue Engineering/methods , Vitamin B Complex/chemistry , Vitamin B Complex/therapeutic use
...